SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: combjelly who wrote (976764)10/30/2016 9:01:18 PM
From: i-node  Read Replies (2) of 1570748
 
While I would never support such a thing, it is important to recognize that there are massive drug costs to the system that are not in Part D at all.

You do realize that chemotherapy drugs are covered under Part B and drugs administered to inpatients are covered under Part A? So, that expenditure for Neulasta (1.2 Billion) or Retuxin (1.5 Billion) is covered under Part B, not Part D.

I don't know what the total is but at worst that is an exaggeration or mistake.

I mean, Obama was going to close Gitmo by the end of 2009. How'd that go?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News